English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Aim: We evaluated the treatment outcome of the patients having cerebrospinal fluid pseudocyst following ventriculo-peritoneal shunt. Materials and Methods: During the period of 1975 to 2005, 392 hydrocephalic patients underwent ventriculo-peritoneal shunt, of these eight developed abdominal cerebrospinal fluid pseudocyst. The medical records regarding the etiology of hydrocephalus, age of shunting, infectious screening, therapy and follow up were evaluated. Results: Cerebrospinal fluid analysis was normal in all except in 4 patients who showed high level of C-reactive protein. One patient had significant abdominal symptoms as pain, vomiting and diarrhea. All were treated by cyst excision, exteriorization of shunt and antibiotic treatment. A new shunt was placed once cerebrospinal fluid cultures were negative. Conclusions: cyst excision, appropriate antibiotic therapy followed by new shunt placement once cerebrospinal fluid cultures are negative constitutes the required treatment for these patients with abdominal pseudocyst.

Abdominal cerebrospinal fluid pseudocysts in patients with ventriculoperitoneal shunts: 30 years of experience*